Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients

2011 ◽  
Vol 127 (2) ◽  
pp. AB101-AB101 ◽  
Author(s):  
B. Zuraw ◽  
T. Craig ◽  
R.F. Lockey ◽  
M. Park ◽  
J. Grant ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
North American ◽  
Hereditary Angioedema ◽  
C1 Inhibitor ◽  
Repeat Treatment ◽  
Acute Attacks

scholarly journals Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema

2015 ◽  
Vol 166 (4) ◽  
pp. 259-266 ◽  
Author(s):  
Angelica Petraroli ◽  
Veronica Squeglia ◽  
Nadia Di Paola ◽  
Alessandro Barbarino ◽  
Maria Bova ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Hereditary Angioedema ◽  
C1 Inhibitor ◽  
Home Therapy

Clinical Studies of Recombinant Human C1 Inhibitor (rhC1INH) in Patients with Acute Attacks of Hereditary Angioedema

2008 ◽  
Vol 121 (3) ◽  
pp. 797 ◽  
Author(s):  
J. Nuijens ◽  
R. Verdonk ◽  
B. Giannetti ◽  
S. Visscher ◽  
M. van Doorn ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Clinical Studies ◽  
C1 Inhibitor ◽  
Acute Attacks

Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study

2013 ◽  
Vol 110 (4) ◽  
pp. 295-299 ◽  
Author(s):  
Marc A. Riedl ◽  
Robyn J. Levy ◽  
Daniel Suez ◽  
Richard F. Lockey ◽  
James W. Baker ◽  
...  
Keyword(s):  
North American ◽  
Hereditary Angioedema ◽  
Efficacy And Safety ◽  
C1 Inhibitor ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Rates of Rebound or Relapse Among Acute Attacks of Hereditary Angioedema Treated with Ecallantide in Open-Label, Repeat-Treatment Study

2012 ◽  
Vol 129 (2) ◽  
pp. AB219
Author(s):  
H.H. Li ◽  
J.A. Bernstein ◽  
D.F. Soteres ◽  
M. Riedl ◽  
W.R. Lumry ◽  
...  
Keyword(s):  
Hereditary Angioedema ◽  
Open Label ◽  
Repeat Treatment ◽  
Acute Attacks
Sign in / Sign up

Export Citation Format

Share Document